Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility EP News Bureau Oct 3, 2024 The Bonds are expected to be rated BB by both S&P and Fitch and will be listed on the Singapore Stock Exchange
